We are live on ! Find out more
SAM

Sectoral Asset Management Portfolio holdings

AUM $121M
1-Year Est. Return 73.47%
This Fund
S&P 500
This Quarter Est. Return
-13.3%
1 Year Est. Return
+73.47%
3 Year Est. Return
+165.77%
5 Year Est. Return
+169.27%
10 Year Est. Return
+1,136.49%
AUM
$580M
AUM Growth
-$257M
Cap. Flow
-$134M
Cap. Flow %
-23.05%
Top 10 Hldgs %
37.84%
Holding
94
New
2
Increased
24
Reduced
33
Closed
31

Top Buys

Rank Stock Value
1
WMGI
Wright Medical Group Inc
WMGI
+$13.2M
2
INSP icon
Inspire Medical Systems
INSP
+$9.36M
3
IRTC icon
iRhythm Holdings
IRTC
+$7.84M
4
IMMU
Immunomedics Inc
IMMU
+$7.22M
5
TNDM icon
Tandem Diabetes Care
TNDM
+$7.21M

Top Sells

Rank Stock Value
1
ARRY
Array Biopharma Inc
ARRY
+$36.8M
2
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$17.3M
3
APLS
Apellis Pharmaceuticals
APLS
+$13.6M
4
AGN
Allergan plc
AGN
+$12M
5
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
+$11.7M

Sector Composition

Rank Sector Weight
1 Healthcare 83.54%
2 Industrials 3.13%
3 Technology 2.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VRTX icon
51
Vertex Pharmaceuticals
VRTX
$123B
$2.4M 0.41%
14,171
-23,600
-62% -$4.17M
COGT icon
52
Cogent Biosciences
COGT
$6.76B
$2.19M 0.38%
379,794
-17,065
-4% -$139K
MTEM
53
DELISTED
Molecular Templates, Inc.
MTEM
$1.94M 0.34%
19,641
-3,692
-16% -$344K
SVRA icon
54
Savara
SVRA
$1.08B
$1.88M 0.32%
710,310
-30,790
-4% -$76.9K
URGN icon
55
UroGen Pharma
URGN
$1.97B
$1.55M 0.27%
65,063
– –
RDY icon
56
Dr. Reddy's Laboratories
RDY
$9.8B
$1.49M 0.26%
196,985
– –
SAGE
57
DELISTED
Sage Therapeutics
SAGE
$1.47M 0.25%
10,500
-13,900
-57% -$2.33M
AGIO icon
58
Agios Pharmaceuticals
AGIO
$2.08B
$1.47M 0.25%
45,400
-34,600
-43% -$1.43M
QTTB icon
59
Q32 Bio
QTTB
$435M
$1.35M 0.23%
+4,132
New +$1.4M
QURE icon
60
uniQure
QURE
$2.78B
$1.16M 0.2%
29,500
+15,000
+103% +$865K
FSTX
61
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
$952K 0.16%
69,164
– –
PHAS
62
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
$817K 0.14%
196,000
+20,000
+11% +$159K
AGN
63
DELISTED
Allergan plc
AGN
$808K 0.14%
4,800
-73,500
-94% -$12M
ABEO icon
64
Abeona Therapeutics
ABEO
$355M
– –
-507
Closed -$61K
BDX icon
65
Becton Dickinson
BDX
$46.4B
– –
-3,090
Closed -$760K
BLRX
66
BioLineRX
BLRX
$12M
– –
-297
Closed -$65K
BPMC
67
DELISTED
Blueprint Medicines
BPMC
– –
-10,984
Closed -$1.04M
CLSD
68
DELISTED
Clearside Biomedical
CLSD
– –
-1,731
Closed -$25K
CRVS icon
69
Corvus Pharmaceuticals
CRVS
$1.1B
– –
-12,594
Closed -$47K
CTMX icon
70
CytomX Therapeutics
CTMX
$690M
– –
-10,058
Closed -$113K
EXAS
71
DELISTED
Exact Sciences
EXAS
– –
-38,400
Closed -$4.53M
FBRX icon
72
Forte Biosciences
FBRX
$1.57B
– –
-1,787
Closed -$4.48M
CBIO
73
Crescent Biopharma
CBIO
$546M
– –
-5,528
Closed -$6.59M
HCM icon
74
HUTCHMED
HCM
$1.96B
– –
-31,628
Closed -$696K
INDP icon
75
Indaptus Therapeutics
INDP
$243M
– –
-392
Closed -$3.81M
1 2
3
4

Similar funds

RIP
Reliant Investment Partners Pinehurst, North Carolina $121M AUM 34.77% 1-Year Est. Return
LFWA
LiftPoint Family Wealth Advisors Far Hills, New Jersey $121M AUM
CF
Conquis Financial Milbrae, California $121M AUM 16.22% 1-Year Est. Return
WIM
Wiregrass Investment Management Thomasville, Georgia $121M AUM
MW
Merited Wealth North Bay Village, Florida $121M AUM
AFC
Avise Financial Cooperative Los Angeles, California $121M AUM
AAA
AG Asset Advisory Los Angeles, California $121M AUM 10.78% 1-Year Est. Return
TGM
Tenzing Global Management San Francisco, California $121M AUM 85.62% 1-Year Est. Return

Sectoral Asset Management's Q3 2019 Portfolio in Review

As of Q3 2019, Sectoral Asset Management held 94 positions worth $580M, down 31% from $836M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Sectoral Asset Management withdrew a net $134M in Q3 2019, closing 31 positions and reducing 33 holdings. Its most notable exit was Array Biopharma Inc, an estimated $36.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 84% of assets, down from 85% a quarter earlier, followed by Industrials and Technology.

Against the trend, Sectoral Asset Management opened a new position in Tabula Rasa HealthCare, Inc. Common Stock worth $6.63M.

  • Sectoral Asset Management's largest Q3 2019 buy was Tabula Rasa HealthCare, Inc. Common Stock: 120,600 shares worth $6.63M.
  • Sectoral Asset Management added most to Wright Medical Group Inc in Q3 2019, an estimated $13.2M increase.
  • Sectoral Asset Management's biggest Q3 2019 reduction was Alnylam Pharmaceuticals, cutting an estimated $17.3M.
  • Sectoral Asset Management fully exited Array Biopharma Inc in Q3 2019, selling an estimated $36.8M.
  • Sectoral Asset Management's ten largest holdings make up 38% of its $580M portfolio in Q3 2019.
  • Sectoral Asset Management opened 2 new positions and closed 31 in Q3 2019.
  • Sectoral Asset Management's portfolio value fell 31% quarter-over-quarter to $580M.

Based on Sectoral Asset Management's 13F filing for Q3 2019, filed 14 Nov 2019.